Chinese CRO GemPharmatech expands in San Diego as industry weighs FDA’s animal testing shift

Title

Chinese CRO GemPharmatech Launches Expanded San Diego Hub Amid Shifts in FDA Animal Testing Guidelines

GemPharmatech, a global CRO specializing in genetically engineered mouse models and preclinical research services, has significantly expanded its U.S. presence with a newly opened and expanded headquarters in San Diego’s primary biotech corridor1 4 5.
The new San Diego facility features a state-of-the-art rodent vivarium and comprehensive laboratory space, designed to enhance support for North American biomedical researchers and drug developers, from animal breeding to full preclinical in vivo pharmacology studies4 5.
This expansion allows U.S.-based researchers to access GemPharmatech’s extensive collection of genetically engineered mouse models locally, resulting in faster study turnaround, increased flexibility, and improved coordination of research projects1 4 5.
The facility is equipped with advanced environmental controls, ensuring high standards of animal welfare and rigorous data quality in line with evolving regulatory and ethical standards4 5.
GemPharmatech’s expansion comes as the industry evaluates recent changes in FDA policy that shift requirements on animal testing, positioning the company to remain a vital resource for both traditional and emerging drug development workflows5.
The move is part of GemPharmatech’s ongoing strategy to invest in and support North American biomedical and pharmaceutical innovation, reinforcing its commitment to collaborative and innovation-driven scientific advancement4 5.